pioglitazone has been researched along with Hepatitis, Autoimmune in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Hepatitis, Autoimmune: A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Schulte, R | 1 |
Wohlleber, D | 1 |
Unrau, L | 1 |
Geers, B | 1 |
Metzger, C | 1 |
Erhardt, A | 1 |
Tiegs, G | 1 |
van Rooijen, N | 1 |
Heukamp, LC | 1 |
Klotz, L | 1 |
Knolle, PA | 1 |
Diehl, L | 1 |
1 other study available for pioglitazone and Hepatitis, Autoimmune
Article | Year |
---|---|
Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.
Topics: Animals; Cells, Cultured; Hepatitis, Autoimmune; Interferon-gamma; Kupffer Cells; Lymphocyte Activat | 2020 |